首页 | 本学科首页   官方微博 | 高级检索  
检索        

氨溴索、酚妥拉明、多巴酚丁胺治疗肺心病顽固性心衰疗效观察
引用本文:张振明,黄琼霞,何莉衍.氨溴索、酚妥拉明、多巴酚丁胺治疗肺心病顽固性心衰疗效观察[J].中国医药导刊,2011,13(2):283+285.
作者姓名:张振明  黄琼霞  何莉衍
作者单位:广东省深圳市宝安区观澜人民医院,深圳,518110
摘    要:目的:探讨氨溴索,酚妥拉明,多巴酚丁胺联合治疗肺心病顽固性心衰的临床疗效。方法:选择综合治疗加合理应用强心剂利尿剂为对照组与综合治疗加用氨溴索,酚妥拉明,多巴酚丁胺为治疗组的对比治疗。结果:治疗组对缓解临床症状,改善肺心功能明显优于对照组。结论:此方案对治疗肺心病顽固性心衰是一种较为有效的方案,较好地改善患者的生活质量,降低死亡率。

关 键 词:肺心病  顽固性心衰/药物疗法  氨溴索  酚妥拉明  多巴酚丁胺

Ambroxol, Phentolamine,Dobutamine Treatment of Pulmonary Heart Disease, Refractory Heart Failure Patients
Zhang Zhen-ming,Huang Qiong-xia,He Li-yan.Ambroxol, Phentolamine,Dobutamine Treatment of Pulmonary Heart Disease, Refractory Heart Failure Patients[J].Chinese Journal of Medicinal Guide,2011,13(2):283+285.
Authors:Zhang Zhen-ming  Huang Qiong-xia  He Li-yan
Institution:(Guanglanin Shenzhen,Guangdong People’s Hospital,Shenzhen 518110,China)
Abstract:Objective:To investigate the ambroxol,phentolamine,dobutamine treating pulmonary heart disease clinical efficacy of refractory heart failure.Methods:A comprehensive treatment and a reasonable application of cardiac,diuretic and comprehensive treatment for the control group plus ambroxol,phentolamine,doqa- tincture treatment group compared amine treatment.Results:The treatment group on the clinical symptoms,changes in heart and lung function than the control group.Conclusions:The program on the treatment of refractory heart failure with pulmonary heart disease is a more effective program.And improved quality of life of patients and reduced mortality.
Keywords:Pulmonary heart disease  Refractory heart failure/drug therapy  Ambroxol  phentolamine  Dobutamine
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号